intermune inc (ITMN:NASDAQ GS)

Executive Profile*

Background*

Dr. W. Scott Harkonen, M.D. served as the Chief Executive Officer and President of CoMentis, Inc. Dr. Harkonen has over 20 years of experience in the biopharmaceutical industry. He served as Chief Executive Officer of CoTherix Inc., since October 2003 and as its Chairman from April 2001 to July 2004. He was the Founder of InterMune Inc. and served as its Chairman since January 2000, Chief Executive Officer and President from 1999 to 2003 and also served as its Consultant. ... From 1995 to 1999, Dr. Harkonen served as Senior Vice President, Product Development and Operations at Connetics Corporation, Biopharmaceutical Company. From 1991 to 1995, Dr. Harkonen served as Vice President of Medical and Regulatory Affairs at Univax Corporation (now NABI). In these positions, he led multiple product development programs, including five successful drug approvals (NDA/BLAs), and was instrumental in numerous private and public financings. Dr. Harkonen serves as a Director of Origen Therapeutics, Inc. He serves on the boards of Directors of several privately-held biopharmaceutical companies including Mondobiotech S.A. He served as a Director of InterMube Inc. since February 1998. He served as a Director of Kalobios Inc. (now KaloBios Pharmaceuticals, Inc.). He served as a Director of Biotechnology Industry Organization and CoMentis, Inc. He served as a Director of CoTherix Inc. from April 2001 to July 2004. He served as Director of the InterMune Inc. from February 1998. Dr. Harkonen holds an B.A. and M.D. from the University of Minnesota and an M.B.A. from the Haas School of Business at the University of California at Berkeley.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ITMN:US	$9.58 USD	-0.38

COMPETITOR COMPENSATION